Astellas 8951-CL-5201

About this trial

Patient Profile

Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma

Where’s this trial being run?

St Vincents University Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: Astellas 8951-CL-5201
Number: CTRIAL-IE 18-44
Full Title:

A Phase 2, Open-Label, Randomized Study to Assess the Antitumor Activity and Safety of Zolbetuximab (IMAB362) in Combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma

Principal Investigator: Ray McDermott
Type:
Sponsor:

Astellas

Recruitment Started: Global:
Ireland:
Global Recruitment Target: 141
Ireland Recruitment Target: 3